Periodic Reporting for period 1 - EyeWideVision (An assessment and treatment tool for visual dysfunctions in children)
Reporting period: 2017-12-01 to 2018-04-30
There is an increasing demand for devices for early diagnosing and better treating visual limitations. According to Persistence Market Research, the global clinical devices for the visual function assessment market is anticipated to grow o USD 42,685 million in 2020 at a CAGR of 6.5%.
WIVI is an assessment and training tool for visual dysfunctions personalized for each user and the specialist based on immersive 3D techniques, which provides a complete cognitive, neural and physic phases assessment of the visual system in its full extension.
The feasibility study has enabled us to validate its business idea. Our scope is to establish WIVI as a worldwide standard in visual dysfunction assessment and training, supporting it in real-time high assessment rates, cheaper and faster clinical practices.
Having confirmed the market acceptance and potential, we ambition to achieve an assembly capacity and commercialize our solution on target markets. We intend to innovate the world of vision care through technological and scientifical innovation at an affordable price to the population. WIVI offers not only assessment but also personalized training of detected dysfunctions, improving reading speed, comprehension, concentration and achieving better social integration, thus major improvement in quality of life of people with visual dysfunctions.